Elite Pharmaceuticals (OTCMKTS:ELTP) Announces Quarterly Earnings Results

Elite Pharmaceuticals (OTCMKTS:ELTP) announced its quarterly earnings results on Thursday. The specialty pharmaceutical company reported ($0.01) earnings per share for the quarter, Zacks reports. Elite Pharmaceuticals had a negative net margin of 8.98% and a positive return on equity of 15.55%.

Elite Pharmaceuticals Stock Performance

Shares of OTCMKTS:ELTP opened at $0.55 on Friday. The company has a current ratio of 3.52, a quick ratio of 2.42 and a debt-to-equity ratio of 0.10. Elite Pharmaceuticals has a 1-year low of $0.12 and a 1-year high of $0.75. The firm has a fifty day moving average price of $0.52 and a 200 day moving average price of $0.44.

Elite Pharmaceuticals Company Profile

Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.